Member Info for Barnacle

The team is on site today at the neighbourhood health simulation; led by PPL. We're excited to be providing the technology for collaboration for this event with our communications platform Bleepa.

https://www.linkedin.com/posts/feedback-medical-ltd_bleepa-neighbourhoodhealthsimulation-activity-7336323400228827136-ByKe?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAIMELYB3jCMTAJfoWG0WbiPY6veZrdjeEU

Possible news on Thursday regarding Neighbourhood Diagnostics Solution.....?

The first ever simulation of the NeighbourhoodHealthService, is coming up on the 5-6 June.

RNS September 19th 2024 - Feedback signs collaboration agreement with a provider of primary care solutions

Feedback plc ("Feedback" or the "Company"), has signed a collaboration agreement with a provider of primary care solutions to explore the opportunities for a novel Neighborhood Diagnostics Solution.

The intention is to explore creating a solution that combines the partners' technology and Bleepa to streamline NHS diagnostic and pathway referrals between primary care, Community Diagnostic Centres (CDCs) and secondary care. It is envisaged the solution will also enable some diagnostic procedures to be referred into community settings such as pharmacy or other diagnostic facilities, creating additional diagnostic capacity to support NHS waitlist recovery.

The parties intend to pilot the solution before pursuing broader national opportunities for contracts. Pilot conversations with customer sites are already underway. A pilot will seek to demonstrate both the continued reduction in outpatient appointment requirement through the combined platform, further reduction in patient wait times through an optimised GP referral process and also the ability to scale the solution at pace to multiple GP practices simultaneously.

The collaboration provides a route to rapidly scale the Bleepa solution and pathway approach, leveraging the existing footprint of the party.

Morning, after listening to Bartu Ahiska's interview, I've got to say I was very impressed with how he came across, and with the prospects that seem to lie ahead in the near term. It seems a no brainer that the EpiSwitch PSE Test should be offered by the NHS. With the awareness of Prostate Cancer increasing due to media coverage, let's hope that this incredible test becomes widely available ASAP.

The ducks are patiently lined up...... ;o)

Could be some news next week.....

The first ever simulation of the NeighbourhoodHealthService, is coming up on the 5-6 June.

In this blog https://lnkd.in/et289yXX, Adam Wall, Data & Analytics Lead at PPL gives insight into the importance of ensuring rich, real-world data is at the core of any Neighbourhood Health Service.

We’ll be at the NHSConfedExpo from 11 – 12 June discussing all things Neighbourhood Health Service related. Make sure you drop by our stand (E109) and say hello.

We’re PPL, the UK’s leading social enterprise management consultancy. Working with you to make the Neighbourhood Health Service work.

We are excited to be joining PPL next week with #Bleepa as the collaboration platform being used by participants during the simulation.

Now this is interesting......

The first ever simulation of the NeighbourhoodHealthService, is a week away!

The NeighbourhoodHealthService is part of a powerful shift in the healthcare system, one that acts earlier, builds stronger community connections and designs services that reflect real lives.

At PPL we’re bringing this to life through the upcoming first ever simulation of the Neighbourhood Health Service in London, collaborating with system partners to test this model and move towards care that is proactive, equitable and truly connected.

https://ppl.org.uk/the-future-of-healthcare-embracing-the-neighbourhood-health-service/

Some positive share price movement this morning.

A lot to look forward to in the next few months :0)

* at least 3 ICBs lined up:

Greater Manchester ICB

Northern Care Alliance NHS Foundation Trust (NCA): NCA has implemented Bleepa across multiple specialties, including cardiology, respiratory, gastroenterology, endocrinology, and haematology, at The Royal Oldham Hospital and Fairfield General Hospital. This expansion led to a 68% increase in users from June 2023 to June 2024, processing over 9,200 patient referrals in that period. An independent evaluation reported a 74% reduction in average referral times, decreasing from 2.1 days to 0.55 days.

Sussex ICB

Queen Victoria Hospital NHS Foundation Trust: As part of a pilot program, Sussex ICB utilized Bleepa alongside CareLocker to support Community Diagnostic Centres (CDCs). The pilot focused on the breathlessness pathway, aiming to integrate diagnostic services across primary and secondary care settings.

Berkshire West ICB

Royal Berkshire NHS Foundation Trust: The trust adopted Bleepa to enhance its clinical communication strategy, moving away from unregulated platforms like WhatsApp. The implementation included features such as virtual multi-disciplinary meetings (MDTs), photocapture for clinical images, and a referral module integrated with the trust’s Electronic Patient Record system.

* News on the collaboration with the Primary Care Provider; From RNS 19th Sept 24:

"The parties intend to pilot the solution before pursuing broader national opportunities for contracts. Pilot conversations with customer sites are already underway. A pilot will seek to demonstrate both the continued reduction in outpatient appointment requirement through the combined platform, further reduction in patient wait times through an optimised GP referral process and also the ability to scale the solution at pace to multiple GP practices simultaneously.

The collaboration provides a route to rapidly scale the Bleepa solution and pathway approach, leveraging the existing footprint of the party."

* Two revenue-generating projects operationalised in India:

o a pilot with a large Asian hospital group

o Tuberculosis ("TB") screening programme with HEAL Foundation

Good find Bill. Feedback have attended a number of conferences in the UAE, so this could be their route in for sales...

From CEO Vertex Linkedin post:

"I'm thrilled to announce a groundbreaking new partnership for Vertex in Healthcare in the UAE! We've officially joined forces with ARJ Medical, led by Bahar Modiri a highly respected and well-established healthcare provider in the region.

This strategic collaboration marks a significant milestone in our shared mission to revolutionize the diagnostic sector of healthcare. By combining Vertex's innovative solutions with ARJ Medical's deep regional expertise, we are poised to bring unparalleled advancements to diagnostic capabilities across the GCC."

A reminder from RNS dated 10th July 2024:

Vertex In Healthcare collaboration to further international expansion

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces a collaboration agreement ("Agreement") with Vertex In Healthcare ("Vertex"), a specialist clinical IT firm with offices in the UK, UAE and South Africa, to combine key technologies and resell each other's products with a view to driving commercial opportunities in multiple markets. The Agreement enables the companies to work together and outlines the key terms which will form the basis of definitive commercial agreements for multiple collaborations.

New article from Feedback:

https://feedbackmedical.com/insights/from-analogue-to-digital-getting-the-basics-right/

Added 50,000 this morning. Looks like we've got some buying at last...... Financial resources for Integrated Care Boards ICBs should start being allocated soon....

Just a change in name PR :

On May 1, 2025, Amati AIM VCT PLC changed its name to Maven Renovar VCT PLC. This name change coincided with a change in investment manager, with Maven Capital Partners taking over from Amati Global Investors.

The Company continues to conservatively manage its finances and remains well funded with cash and short-term investments of £6.6m as at 31 March 2025 following the successful £6.1m (gross) fundraise in November 2024.

So with a monthly cashburn of £300,000, Feedback have a runway of 21 months runway from today, and this is without the addition of future revenues. Plenty of time in my view to land those ICB contracts, and more. I suspect we will get some news sooner than people think, post May.

News article with link to webinar:

https://feedbackmedical.com/feedback-medical/reimagining-elective-care-a-new-diagnostics-first-outpatient-model/

In the 2025/26 financial year, financial resources for Integrated Care Boards (ICBs) began being allocated from 1 April 2025, in line with the start of the NHS financial year. NHS England published final revenue allocations on 30 January 2025, with further updates in April 2025 to reflect any policy or technical adjustments.

Key Points:

Allocations began on 1 April 2025: This is when ICBs officially start drawing down their 2025/26 funding to support operations.

Funding is included in core allocations: The Elective Recovery Fund (ERF) is no longer a standalone budget—it's embedded into each ICB's core allocation.

Phased distribution: While the total annual funding is confirmed in advance, drawdowns typically occur monthly or quarterly, contingent on financial planning and performance criteria.

Answer courtesy of ChatGBT

​Integrated Care Boards (ICBs) are required to submit their final financial and operational plans for the 2025/26 financial year by April 30, 2025. This deadline is set by NHS England to ensure timely allocation of resources and alignment with national healthcare priorities.​

In preparation for this submission, ICBs should consider the following key points:​

Financial Reset: NHS England has emphasized the need for a "fundamental reset" of financial regimes due to a projected £6.6 billion budget deficit. ICBs are expected to identify potential service reductions and cost-saving measures to address this shortfall. ​

Productivity Improvements: ICBs are encouraged to achieve a 4% improvement in productivity and reduce their cost base by at least 1% to accommodate demand growth within constrained budgets. ​

Elective Recovery Targets: Efforts should be made to improve Referral to Treatment (RTT) performance, with a national goal for 65% of patients to receive treatment within 18 weeks by March 2026. ​

News article from yesterday - Digital collaboration tools can support clinical safety improvements

https://feedbackmedical.com/insights/digital-collaboration-tools-can-support-clinical-safety-improvements/

Thanks for posting Vas, looks very promising for Feedback….

New position being advertised. Must be for all the new contracts..... Ho Hum

https://feedbackmedical.com/vacancy/technical-support-manager/

Royal Berkshire NHS Trust and Northern Care Alliance Contracts should be renewed this month, and possibly news on the CDC Pathway Pilot at the NCA site in Oldham which concluded on the 31st March.

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, is pleased to announce that it has secured further funding to extend the delivery of its Community Diagnostic Centre ("CDC") pathway pilot at the Northern Care Alliance NHS Foundation Trust ("NCA") site in Oldham.

Feedback has successfully supported Oldham CDC's application for further pathway funding from the 2024-25 NHS England budget, securing a paid contract extension as outlined in the original pilot announcement, on 21 March 2024. This further funding is for £69,000 with an initial 50% paid from the NHSE H1 budget to 30 September 2024, with the balance expected from the NHSE H2 budget to continue the pilot to 31 March 2025. The pilot is focused on breathlessness, further demonstrating the impact of a pathway approach on CDC utilisation and wider patient wait times. The data generated will complement positive findings from past and ongoing pilots, building the business case for further expansion and funding.

The coverage of the NCA's Bleepa® based digital referral system, which is based on a separate Bleepa® contract with Feedback, has also been significantly expanded since December 2023, when it supported six specialities at Oldham and one at Fairfield General Hospital. Its total user number has increased 68% between June 2023 and June 2024 with over 1,400 users at the sites now generating over 9,200 patient referrals during this period alone. It now supports eleven specialties, including Endocrinology and Haematology at Oldham, and five specialities, including Cardiology and Respiratory at Fairfield.

An independent report by Unity Insights published in October 2023 found that the NCA identified a dramatic reduction in clinical response times after switching to Bleepa® from paper-based referral systems, after examining 10,000 referrals made between July 2021 to April 2023. The report estimated that the collective time savings would be worth £819,000 to the NCA over 5 years and, if adopted across the whole Greater Manchester Integrated Care Board, could free up £7.7m in savings over the same period.

Some nice buying, hopefully flush out the background seller, and then we should see some proper movement.....